Land: Australien
Sprog: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
latanoprost, Quantity: 0.05 mg/mL; timolol maleate, Quantity: 6.83 mg/mL (Equivalent: timolol, Qty 5 mg/mL)
Aspen Pharmacare Australia Pty Ltd
Eye Drops, solution
Excipient Ingredients: hydrochloric acid; water for injections; sodium chloride; dibasic sodium phosphate; sodium hydroxide; benzalkonium chloride; monobasic sodium phosphate monohydrate
Ophthalmic
3 x 2.5 mL, 1 x 2.5 mL
(S4) Prescription Only Medicine
The reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. Xalacom should not be used to initiate therapy.
Visual Identification: clear, colourless liquid; Container Type: Bottle; Container Material: LDPE; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2002-01-02
1 XALACOM ® _Latanoprost/Timolol maleate _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Xalacom. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using Xalacom against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT XALACOM IS USED FOR Xalacom is used to lower raised pressure in the eye and to treat glaucoma. Glaucoma is a condition in which the pressure of fluid in the eye may be high. However, some people with glaucoma may have normal eye pressure. Glaucoma is usually caused by a build up of the fluid which flows through the eye. This build up occurs because the fluid drains out of your eye more slowly than it is being pumped in. Since new fluid continues to enter the eye, joining the fluid already there, the pressure continues to rise. This raised pressure may damage the back of the eye resulting in gradual loss of sight. Damage can progress so slowly that the person is not aware of this gradual loss of sight. Sometimes even normal eye pressure is associated with damage to the back of the eye. There are usually no symptoms of glaucoma. If glaucoma is not treated it can lead to serious problems, including total blindness. In fact, untreated glaucoma is one of the most common causes of blindness. Xalacom is made up of 2 active ingredients, latanoprost and timolol maleate. Latanoprost works by allowing more fluid to flow out from within your eye(s). Timolol maleate lowers the pressure in the eye by reducing the production of fluid. Latanoprost belongs to a family of medicines called prostaglandin agonists. Timolol maleate belongs to a family of medicines called beta- blockers. Although Xalacom helps control your glaucoma it does not cure it. So you must keep Læs hele dokumentet
Page 1 of 17 AUSTRALIAN PRODUCT INFORMATION – XALACOM (LATANOPROST AND TIMOLOL MALEATE) EYE DROPS 1. NAME OF THE MEDICINE Latanoprost and timolol maleate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Xalacom is a combination eye drop containing latanoprost and timolol maleate. Latanoprost is a prostaglandin F 2α analogue. Xalacom is a sterile, isotonic solution containing 50 micrograms/mL of latanoprost and 5 mg/mL of timolol (6.83 mg timolol maleate) in an aqueous buffer solution of pH 6.0. Each 5 mL bottle contains 2.5 mL eye drop solution corresponding to a minimum of 80 drops of solution. One drop contains approximately 1.5 µg latanoprost and 150 µg timolol. For the full list of excipients, see Section 6.1 List of excipients. 3. PHARMACEUTICAL FORM Eye drops, solution. The solution is a clear and colourless liquid, filled in a polyethylene container. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. Xalacom should not be used to initiate therapy. 4.2 DOSE AND METHOD OF ADMINISTRATION DOSAGE _RECOMMENDED DOSAGE FOR ADULTS (INCLUDING THE ELDERLY) _ Recommended therapy is one eye drop in the affected eye(s) once daily. If one dose is missed, treatment should continue with the next dose as normal. The use of Xalacom may be considered in patients who require both timolol and latanoprost, but it is unknown whether patients who are adequately controlled with timolol given twice Page 2 of 17 daily plus latanoprost given once daily will be as well controlled with Xalacom given once daily. Xalacom should not be used to initiate therapy. Xalacom should not be given more than once daily because latanoprost is most effective at this dosage. If there is inadequate response to Xalacom, consideration should be given to using the individual agents with timolol dose twice daily. METHOD OF ADMINISTRATION Læs hele dokumentet